Diagnostic utility of whole genome sequencing in adults with B-other acute lymphoblastic leukemia.
Saved in:
| Title: | Diagnostic utility of whole genome sequencing in adults with B-other acute lymphoblastic leukemia. |
|---|---|
| Authors: | Leongamornlert D; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Hinxton, United Kingdom., Gutiérrez-Abril J; Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY., Lee S; Department of Haematology, University College London (UCL) Cancer Institute, London, United Kingdom., Barretta E; Leukaemia Research Cytogenetics Group, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom., Creasey T; Leukaemia Research Cytogenetics Group, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom., Gundem G; Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY., Levine MF; Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY., Arango-Ossa JE; Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY., Liosis K; Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY., Medina-Martinez JS; Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY., Zuborne Alapi K; Department of Haematology, University College London (UCL) Cancer Institute, London, United Kingdom., Kirkwood AA; Cancer Research UK & UCL Cancer Trials Centre, UCL Cancer Institute, UCL, London, United Kingdom., Clifton-Hadley L; Cancer Research UK & UCL Cancer Trials Centre, UCL Cancer Institute, UCL, London, United Kingdom., Patrick P; Cancer Research UK & UCL Cancer Trials Centre, UCL Cancer Institute, UCL, London, United Kingdom., Jones D; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Hinxton, United Kingdom., O'Neill L; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Hinxton, United Kingdom., Butler AP; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Hinxton, United Kingdom., Harrison CJ; Leukaemia Research Cytogenetics Group, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom., Campbell P; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Hinxton, United Kingdom., Patel B; Department of Haemato-Oncology, Barts Cancer Institute, Queen Mary University, London, United Kingdom., Moorman AV; Leukaemia Research Cytogenetics Group, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom., Fielding AK; Department of Haematology, University College London (UCL) Cancer Institute, London, United Kingdom., Papaemmanuil E; Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY. |
| Source: | Blood advances [Blood Adv] 2023 Aug 08; Vol. 7 (15), pp. 3862-3873. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
